Herantis Pharma Oyj
HRPMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,940 | $280 | -$9,324 | -$12,767 |
| Dep. & Amort. | $0 | $0 | $160 | $2,720 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,565 | $217 | -$20 | $114 |
| Other Non-Cash | -$40 | -$5,133 | $240 | -$0 |
| Operating Cash Flow | -$6,545 | -$4,636 | -$8,944 | -$9,934 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,500 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $1,026 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $607 | -$210 | $0 |
| Investing Cash Flow | -$474 | $607 | -$210 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$11 | -$150 | $0 |
| Stock Issued | $0 | $4,507 | $8,710 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,156 | $0 | $0 | $4,034 |
| Financing Cash Flow | $2,151 | $4,496 | $8,559 | $4,034 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,868 | $467 | -$1,404 | -$5,900 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,503 | $5,036 | $6,439 | $12,339 |
| End Cash | $635 | $5,503 | $5,036 | $6,439 |
| Free Cash Flow | -$6,545 | -$4,636 | -$8,944 | -$9,934 |